Evidence map›Paper›PMID 39779302›Full record

ArticleFunction (Oxford, England)2025

Aryl Hydrocarbon Receptor Activation Promotes Effector CD4+ T Cell Homeostasis and Restrains Salt-Sensitive Hypertension.

Patrick A Molina, Claudia J Edell, Luke S Dunaway, Cailin E Kellum, Rachel Q Muir, Melissa S Jennings, Jackson C Colson, Carmen De Miguel, Megan K Rhoads, Ashlyn A Buzzelli and 8 more

Abstract read
In one paragraph

Article in Function (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Patrick A MolinaCardio-Renal Physiology and Medicine Section, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35223, USA.
Claudia J EdellCardio-Renal Physiology and Medicine Section, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35223, USA.
Luke S DunawayCardio-Renal Physiology and Medicine Section, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35223, USA.
Cailin E KellumCardio-Renal Physiology and Medicine Section, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35223, USA.
Rachel Q MuirDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL 35223, USA.
Melissa S JenningsDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL 35223, USA.
Jackson C ColsonCardio-Renal Physiology and Medicine Section, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35223, USA.
Carmen De MiguelCardio-Renal Physiology and Medicine Section, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35223, USA.ORCID 0000-0002-2323-3670
Megan K RhoadsCardio-Renal Physiology and Medicine Section, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35223, USA.
Ashlyn A BuzzelliDepartment of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL 35223, USA.
Laurie E HarringtonDepartment of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL 35223, USA.
Selene Meza-PerezDivision of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35223, USA.
Troy D RandallDivision of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35223, USA.
Davide BottaDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35223, USA.
Dominik N MüllerExperimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin Berlin.
David M PollockCardio-Renal Physiology and Medicine Section, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35223, USA.ORCID 0000-0002-0233-2362
Craig L MaynardDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL 35223, USA.
Jennifer S PollockCardio-Renal Physiology and Medicine Section, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35223, USA.ORCID 0000-0003-1956-0449

Funding

Prospective Effects of Early Life Stress and Protective Factors on Vascular Function and Inflammation in Young AdulthoodP01HL158500 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Sylvie Mrug · 2023 to 2026
$11.1M
Deep South KUH Premier Research - Interdisciplinary Mentored Education (PRIME) Training CoreTL1DK139566 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI DAVID M POLLOCK · 2023 to 2026
$3.6M
Deep South KUH Premier Research- Interdisciplinary Mentored Education (PRIME) Networking CoreU2CDK133422 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Kelly Hyndman · 2023 to 2026
$2.8M
Timing of Diet and Kidney Pathophysiology in Diet-Induced ObesityR01DK134562 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI DAVID M POLLOCK, Jennifer S Pollock · 2023 to 2026
$2.6M
CD4 T cell stemness and inflammatory bowel diseaseR01DK125870 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HARRINGTON, LAURIE ELLEN · 2020 to 2023
$1.5M
PRedOctoral PhD and MD research training in TEams (PROmoTE)R25DK112731 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Orlando M Gutierrez, Jennifer S Pollock · 2019 to 2026
$741k
Novel Endothelial and Immunologic Mechanisms of Pathophysiology in Sickle Cell DiseaseF31HL151264 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MOLINA, PATRICK AXEL · 2019 to 2021
$124k
Time Restricted Feeding in Diet Induced Obesity Improves Aortic Damage and Endothelial Function Through Reducing Th17 CellsF31HL167626 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI EDELL, CLAUDIA · 2023 to 2024
$87k
Deutsche Forschungsgemeinschaft 394046635-SFB 1365Deutsches Zentrum für Herz-Kreislauf-Forschung 81Z0100106NHLBI NIH HHS F31 HL167626NHLBI NIH HHS P01 HL158500NIDDK NIH HHS R01 DK125870NIDDK NIH HHS R01 DK134562NIDDK NIH HHS R25 DK112731NIDDK NIH HHS TL1 DK139566NIDDK NIH HHS U2C DK133422NIH HHS F31HL151264
6 · The paper itself

Abstract

Excess dietary salt and salt-sensitivity contribute to cardiovascular disease. Distinct T cell phenotypic responses to high salt and hypertension, as well as influences from environmental cues, are not well understood. The aryl hydrocarbon receptor (AhR) is activated by dietary ligands, promoting T cell and systemic homeostasis. We hypothesized that activating AhR supports CD4+ homeostatic functions, such as cytokine production and mobilization, in response to high salt intake while mitigating salt-sensitive hypertension. In the intestinal mucosa, we demonstrate that a high-salt diet (HSD) is a key driving factor, independent of hypertension, in diminishing interleukin 17A (IL-17A) production by CD4+ T (Th17) cells without disrupting circulating cytokines associated with Th17 function. Previous studies suggest that hypertensive patients and individuals on a HSD are deficient in AhR ligands or agonistic metabolites. We found that activating AhR augments Th17 cells during experimental salt-sensitive hypertension. Further, we demonstrate that activating AhR in vitro contributes to sustaining Th17 cells in the setting of excess salt. Using photoconvertible Kikume Green-Red mice, we also revealed that HSD drives CD4+ T cell mobilization. Next, we found that excess salt augments T cell mobilization markers, validating HSD-driven T cell migration. Also, we found that activating AhR mitigates HSD-induced T cell migration markers. Using telemetry in a model of experimental salt-sensitivity, we found that activating AhR prevents the development of salt-sensitive hypertension. Collectively, stimulating AhR through dietary ligands facilitates immunologic and systemic functions amid excess salt intake and restrains the development of salt-sensitive hypertension.

Indexed as

CD4-Positive T-LymphocytesHomeostasisHypertensionReceptors, Aryl HydrocarbonSodium Chloride, DietaryTh17 CellsAnimalsInterleukin-17Intestinal MucosaMaleMiceMice, Inbred C57BLInterleukin-17Receptors, Aryl HydrocarbonSodium Chloride, Dietaryaryl hydrocarbon receptorblood pressurehigh-salt dietsalt-sensitive hypertensionTh17

Identifiers

PMID39779302
PMCPMC11931625

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.